Browse articles from EyeWorld.org related to the retina. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ Full results from Phase 3 study for presbyopia-correcting eye drop ➤ Cells from two donors treat dozens of patients with corneal endothelial disease ➤ Study: Dry eye treatment reduces halos after cataract surgery ➤ NDA accepted for IND application for novel, investigational dry eye drug ➤ Acquisition of ophthalmic drug candidate ➤ ASCRS events
➤ FDA grants IDE for MIGS device to start pivotal trial ➤ Breakthrough therapy designation granted for possible Stargardt treatment ➤ Refractive surgery uptick continues ➤ First patient dosed in trial for light-activated optogenetic monotherapy for RP ➤ Diagnostic device company acquires ophthalmic device manufacturer ➤ Two ophthalmic companies partner ➤ ASCRS news and events
➤ New visual prosthesis heads to clinical trial ➤ FDA grants Fast Track designation to investigational wet AMD therapy ➤ Patient enrollment complete in Phase 3 trial for investigational, first-in-class eye drop for DED ➤ FDA agrees to pivotal trial design for investigational treatment of geographic atrophy secondary to AMD ➤ ASCRS news and events
➤ Combination pharmaceutical therapy being investigated for presbyopia meets study endpoints ➤ Positive results in Phase 2 clinical trial for IOP-lowering agent ➤ Phase 3 results from study of gene therapy for retinal neurodegenerative diseases ➤ Positive safety results in Phase 1 anti-VEGF treatment ➤ ASCRS news and events
➤ FDA approves spheric, monofocal IOL ➤ Phase 2/3 study of gene therapy for retinitis pigmentosa does not meet primary endpoint ➤ Study: Compounded cyclosporine drop significantly improves OSDI scores ➤ Subretinal injector receives FDA pre-market approval ➤ Three companies form strategic alliance to develop cell therapies ➤ ASCRS events
➤ FDA approves new presbyopia-correcting IOL ➤ New way to evaluate sickle cell retinopathy ➤ Positive Phase 2a data on novel, topical dry eye disease drug candidate ➤ Second Phase 3 trial initiated for Demodex blepharitis treatment ➤ Large-scale, randomized controlled trial replicated with real-world data set ➤ ASCRS events
➤ FDA approves next-generation phaco machine ➤ Study: Endogenous compound reduces glaucomatous vision loss independent of IOP ➤ Successful transplant of stem cell-derived retinal ganglion cells in lab ➤ Phase 2 clinical trial for intravitreal dexamethasone implant ➤ ASCRS events
➤ Researchers develop living 3D lab model of human retina ➤ Real-world data shows home AMD monitoring program is better than standard of care ➤ FDA approves new ophthalmic viscosurgical device ➤ Positive topline data for photobiomodulation for dry AMD ➤ Positive topline data for bevacizumab-vikg for retinal indications
OCT is a quick and non-invasive imaging modality with a high sensitivity in diagnosing macular conditions. The ASCRS/EyeWorld Journal Club reviewed a paper by Leung et al. that analyzed a cases series to evaluate the utility of macular OCT in cataract surgery preop assessments.
When performing cataract surgery, it’s important to be aware of other conditions and comorbidities, including issues with the retina. Several physicians discussed how to handle patients with retina abnormalities prior to cataract surgery.